Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2005
02/23/2005EP1507526A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
02/23/2005EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives)
02/23/2005EP1507514A2 Controlled release compositions of estradiol metabolites
02/23/2005EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
02/23/2005EP1175224B1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
02/23/2005EP1133497B1 Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid
02/23/2005EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents
02/23/2005EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors
02/23/2005EP1035870B1 Compositions and methods for treatment of hepatitis c virus-associated diseases
02/23/2005EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
02/23/2005CN1585775A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials
02/23/2005CN1585772A Chemokine receptor antagonists and methods of use thereof
02/23/2005CN1585767A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585766A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585765A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585764A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5
02/23/2005CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection
02/23/2005CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists
02/23/2005CN1585745A Hydroxyfattysulfonic acid analogs
02/23/2005CN1585648A Enamel matrix protein compositions for modulating immune response
02/23/2005CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases
02/23/2005CN1585641A Hydrazono-malonitriles
02/23/2005CN1585638A Linked biaryl compounds
02/23/2005CN1585634A Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor
02/23/2005CN1585631A Process for preparing quick dissolving, high loading ribavirin compositions
02/23/2005CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent
02/23/2005CN1583795A Human interferon analogue with long-lasting biological effects
02/23/2005CN1583792A Vitellus immune globulin for preventing prawn virus, tis preparing method and use thereof
02/23/2005CN1583787A Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus
02/23/2005CN1583785A Neutral and variable sites of cytomembrane protein M2 of influenza virus and their use
02/23/2005CN1583783A Licorice acid double salt, preparing method and use thereof
02/23/2005CN1583769A 9-[2-(phosphonomethoxy)ethyl] adenine bicycloalkoxide and its preparation
02/23/2005CN1583758A Use of Maituolaicin
02/23/2005CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics
02/23/2005CN1583747A Pterin mononitrogen monoxide synthase inhibitor
02/23/2005CN1583746A Methylamino-pterin derivative with inhibiting nitric oxide synthetase function
02/23/2005CN1583724A 7-(4, 4-dimethyl 3-aminomethylpentazane-1-radicle) substituted, quinoline carboxylic acid derivative and its preparation
02/23/2005CN1583175A Skin targeting medicinal composition and its preparation and use
02/23/2005CN1583171A Preparation of immuno-stimulation composition for hemolycin in monad
02/23/2005CN1583170A Medicine for human lysozyme against virus and drug-fast bacteria and its preparation
02/23/2005CN1583169A Use of human lysozyme in preparation of medicine for hemorrhoid
02/23/2005CN1583166A Chinese forest frog bactericidal peptide spray agent and its preparation
02/23/2005CN1583165A Gel gent of Chiense forest frog bactericidal peptide
02/23/2005CN1583163A Preparing procedure for enteric soluble capsules of transfer factor
02/23/2005CN1583158A Medicinal composition for wind-cold pathogen by exopathogen and its preparation
02/23/2005CN1583152A Anti-virus capsules of Jinhao
02/23/2005CN1583138A Chinese medicinal composition for supplementing Qi, nourishing heart and calming mind and its preparation and identification
02/23/2005CN1583134A Effervescent tablets of taraxacum mongolicum and their preparation
02/23/2005CN1583130A Frozen dry powder injection of houttuynia cordata and its preparation
02/23/2005CN1583121A Preparation and quality control of anti-catch-cold capsules of chrysanthemum flower and isatis root
02/23/2005CN1583114A Chinese medicine of atypical pneumonia Ke-3 and its preparation
02/23/2005CN1583113A Chinese medicine of atypical pneumonia Ke-1 and its preparation
02/23/2005CN1583090A Spray agent of aromatic turmeric rlizome oil and its preparation
02/23/2005CN1583086A Chinese medicine for relieving exterior syndrome, regulating stomach and eliminatnig dampness and its production
02/23/2005CN1583077A Prescription of
02/23/2005CN1583073A Chinese patent medicinal prescription for catch-cold
02/23/2005CN1583055A Chinese medicinal capsules for disinfecting and relieving toxicity and their preparation
02/23/2005CN1583052A Extraction of canarium leaves
02/23/2005CN1583047A Anti-virus houttuynia cordate medicine and its preparation
02/23/2005CN1583039A Medicine for replenishing liver and detoxicating
02/23/2005CN1583038A Skin bactericidal medicine and its preparation
02/23/2005CN1583023A Common goldenrod medicine gainst catching cold and its preparation
02/23/2005CN1583021A Chinese medicinal preparation for hepatitis and its preparing method (2)
02/23/2005CN1583020A Chinese medicinal preparation for hepatitis and its preparing method (1)
02/23/2005CN1583006A Medicinal liquid for Hong Kong foot
02/23/2005CN1583005A External used medicines for Hong Kong foot and tinea manuum
02/23/2005CN1582993A Preparation of medicine for parotitis
02/23/2005CN1582981A Chinese medicinal composite preparation against virus
02/23/2005CN1582969A Chinese medicine for lymphnode tuberculosis and its preparation
02/23/2005CN1582954A Composition of roxithromycin and ambroxol
02/23/2005CN1582950A Medicinal composition and its preparation and use
02/23/2005CN1582945A Powder injections of composite monoammonium glycyrrhizinate and their preparation
02/23/2005CN1582942A Compoiste preparation of cefuoxime sodium
02/23/2005CN1582941A Bactericidal medicinal composition
02/23/2005CN1582936A External used gel of Jiatishacin and its preparation
02/23/2005CN1582926A Micro-capsules of berberine hydrochloride and their preparations
02/23/2005CN1582921A Use and medicinal composition of eremophilane lactone for inhibiting hepatitis B virus
02/23/2005CN1582912A L-onithine and L-aspartic acid composition
02/23/2005CN1582909A Composite preparation containing florfenicol for animals
02/23/2005CN1190491C PRV-gene and use thereof
02/23/2005CN1190440C Triazolo-epothilones
02/23/2005CN1190439C Tetracyclic fluoroquinolone carboxylic acid, its preparation method and medicinal composition as active component
02/23/2005CN1190425C Six kinds of isoquinoline alkaloid
02/23/2005CN1190229C Medicine for curing hepatitis B
02/23/2005CN1190223C Chinese medicine preparation for treating sepsis and its preparation method
02/23/2005CN1190221C Medicine for curing hepatitis B
02/23/2005CN1190214C Traditional Chinese medicinal granules for preventing and curing prawn viral and bacterial diseases
02/23/2005CN1190213C External used Chinese medicine adhesive plaster for curing appendicitis
02/23/2005CN1190196C Anti-inflammation and antibiotic external synthesized medicine, soluble hemostatic gauze and its processing
02/23/2005CN1190190C Antiviral and antibacterial cantharidinic anhydride medicine composition and its prepn. process
02/22/2005US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate
02/22/2005US6858723 Amphiphile cyclodextrins, preparation and use thereof for solubilizing organized systems and incorporating hydrophobic molecules
02/22/2005US6858722 Oligomer phosphoramidite compositions and processes for synthesizing the same
02/22/2005US6858706 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
02/22/2005US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors
02/22/2005US6858647 Administering retinoid such as, 6-(3-(1-Adamantyl)-4-methoxy-5-hydroxyphenyl)-2-naphthoic acid benzoic acid for therapy of and prophylaxis of bacterial infection
02/22/2005US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations
02/22/2005US6858635 Photoreceptive detectors such as 2-(4-(4-((5S)-5-((Acetylamino )methyl)-2-oxo-3-oxazolidinyl)-2-fluorophenyl)-1-piperazinyl)-2-oxoethyl-4 -azido-2-hydroxy-5-iodobenzoate, used for analyzing binding in grampositive and negative bacteria
02/22/2005US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors